This website (the “Hong Kong Website”) is maintained by Citigroup Global Markets Asia Limited and/or its affiliates (collectively the “Website Owner”). Access to the Hong Kong Website and documents and information published herein (the “Materials”), and their distribution, is subject to the following disclaimer.
Information/Access
This Hong Kong Website is only directed at and intended for residents of Hong Kong only. It may be illegal to download any information from the Hong Kong Website in other countries and the Website Owner disclaims all responsibility if you download any information from the Hong Kong Website in breach of any law of country in which you are residing. The Materials in this website must not be relied, or acted, upon by persons outside Hong Kong. By entering this Hong Kong Website, you confirm that you are a resident of Hong Kong and agree to be bound by the following disclaimer.
Persons accessing this Hong Kong Website or who may possess any information contained herein should inform themselves about, and observe and comply with, any applicable restrictions (including those set out herein) at their own cost and expense and without liability to the Website Owner. Reproduction, distribution, transmission, disclosure or publication of any information contained herein in any other places or to persons to whom such distribution, transmission, disclosure or publication is not permitted under the applicable laws or regulations of such places is strictly prohibited. In particular, information contained herein may not be taken or transmitted into the United States or distributed, directly or indirectly, in the United States or to any U.S. person (as defined in Regulation S under the U.S. Securities Act of 1933). In order to comply with the applicable laws and regulations, the contents of the Hong Kong Website are designed for residents of Hong Kong only and you should not access, browse and/or download any of the contents contained in the Hong Kong Website outside of Hong Kong.
No offer / advice / recommendation
The Materials contained in this Hong Kong Website are provided for information and discussion purposes only and do not constitute or form an (or any part of an) offer, invitation, solicitation, inducement, advice or recommendation, to acquire, dispose of, subscribe for or underwrite any structured products contained, referred to or mentioned in the Materials or this Hong Kong Website (the “Structured Products”). The Materials do not constitute any advice or any form of recommendation to purchase or sell the Structured Products or to conclude any transaction. Nothing contained herein shall form the basis of any contract or commitment whatsoever. Neither this Hong Kong Website nor the Materials shall be construed as an advertisement, inducement or representation of any kind or form whatsoever.
The Materials have been prepared for the intended recipients in general only and do not take into account the particular needs of any specific recipient.
No verification
The Materials are based on information obtained from public sources which are considered by the Website Owner to be reliable. However, the Website Owner has not verified the Materials, and such Materials may be incomplete or inaccurate. Opinions, estimates and other information contained in the Materials may be changed or withdrawn without notice. The Website Owner is not under any obligation to update or supplement the Materials. None of the Website Owner and/or its associates and connected persons, respective directors, senior officers and/or employees (including persons involved in the preparation or issuance of the Materials on this Hong Kong Website) (collectively, "Citigroup") or any information provider makes any representation or warranty, express or implied, of any kind as to the truth, accuracy, completeness, adequacy or reasonableness of the Materials or as to the fitness of any such Materials for any purpose. The Materials contained in this Hong Kong Website are published for reference only and shall not to be relied or acted upon as authoritative, without either the recipient's own independent verification or exercise of independent judgment.
Any indicative pricing levels, disclosure materials, valuations and other analysis published on the Hong Kong Website have been prepared on assumptions and parameters that reflect our good faith determinations. The assumptions and parameters used are not the only ones which could have reasonably been selected, and accordingly, no guarantee is given in respect of the accuracy, reasonableness or completeness of such quotations, disclosure or analysis. No representation or warranty is made that any indicative return or performance will be achieved in the future. Such information does not constitute investment advice by the Website Owner and are for information purposes only.
Risks factors for Structured Products
The Structured Products are non-collateralised product. If the Issuer becomes insolvent or defaults, you may not recover part or all of the amount due.If you invest in the Structured Products, you are relying on the creditworthiness of the Issuer. The price of the Structured Products may fall in value as rapidly as it may rise and investors may sustain a total loss of their investment. It is not possible to predict whether the secondary market for the Structured Products will be liquid or illiquid. Citigroup Global Markets Asia Limited may be the only liquidity provider for the Structured Products. Any opinions, forecasts or estimates herein constitute a judgment as of the date the information is published, and there is no assurance that future results or events will be consistent with any such opinions, forecasts or estimates. You are cautioned that actual results may differ materially from those set forth in any forward-looking statements. Past performance is also not indicative of future results.
Callable bull/bear contracts (“CBBCs”) have a mandatory call feature. Subject to the terms and conditions of CBBCs as set out in the Base Listing Document (including any addendum thereto), CBBCs will be automatically terminated when the spot price / spot level of the underlying asset reaches the call price / call level during the observation period, in which case, you will not receive any cash payment (for category N CBBCs) or may receive a cash payment called the residual value (for category R CBBCs).
Prospective investors should therefore ensure that they understand the nature and risks of the Structured Products and should, where applicable, consult their own legal, tax, accounting, financial and other professional advisers to ensure that any decision to invest in the Structured Products is suitable with regard to such investor’s specific circumstances and financial position. Citigroup assumes no fiduciary responsibility or liability for any consequences, financial or otherwise, arising from the subscription or purchase of the Structured Products.
In respect of each issue of the Structured Products, you should carefully review and understand the terms and conditions of the Structured Products, together with the financial and other information of the Issuer, as set out in the Base Listing Document (including any addendum thereto), and the relevant Supplemental Listing Document. These documents may be obtained from the office of the Sponsor, Citigroup Global Markets Asia Limited, at 50th Floor, Champion Tower, Three Garden Road, Central, Hong Kong.
Members of Citigroup may take proprietary positions and may have long or short positions or other interests in the Structured Products and may purchase and/or sell the Structured Products at any time in the open market or otherwise, in each case whether as principal, agent or as market maker. Citigroup is or may also be involved in other financial, investment and professional activities which may on occasion give rise to interests or a conflict of interests in respect of the securities which are the subject of this Hong Kong Website.
No liability
Citigroup does not accept any liability whatsoever (in negligence or otherwise) for any loss howsoever arising from any use of this Hong Kong Website or its contents or otherwise arising in connection therewith. Without prejudice to the generality of the foregoing, none of the members of Citigroup or any information provider will be liable to anyone for any interruption, inaccuracy, error or omission, regardless of cause, in the information on the Hong Kong Website or for any kind of damages arising in connection therewith. Further, communications over the internet and by email are not secure and there is a risk that information may be intercepted, lost or destroyed. Citigroup does not accept any liability for any such occurrence and do not warrant that any communication or attachments or this Hong Kong Website will be free from viruses, worms or other harmful components.
Privacy
Any personal information supplied by you through this Hong Kong Website will be kept strictly confidential and, save as expressly provided, will only be used in ways which you have consented to. By accessing this Hong Kong Website, you are deemed to consent to the Website Owner’s use of information collected from you for marketing, planning, product development and research purposes. Please read the privacy policy statement for this Hong Kong Website www.citifirst.com.hk to understand how your personal information will be treated when you use this site.
Copyright and trademarks
Except where expressly stated, copyright in the information contained in this Hong Kong Website is owned by or licensed to the Website Owner. The information may not otherwise be reproduced and must not be distributed or transmitted to any other person or incorporated in any way into another site, document or other material. The use of any trademarks and logos displayed on this site is strictly prohibited unless written permission for such use is obtained from the Website Owner and/or, where relevant, such third party, which may own the trademarks and logos.
Hyperlinks
This Hong Kong Website may contain links to other web sites operated by entities which do not belong to Citigroup. These links have been provided solely for you to obtain further information about other relevant products and entities in the market. Members of Citigroup have no control over the information on these sites or the products or services on them, and therefore make no representations and accepts no responsibility regarding their contents. Inclusion of a link to a third party site should not be construed as an endorsement of such third party site by the Website Owner or that party's endorsement of this Hong Kong Website. You are advised to make your own enquiries in relation to third parties described or linked on this Hong Kong Website. Please note that you will be subject to the terms of use of the other sites that you visit.
Amendments and severability
The Website Owner reserves the right to change the Hong Kong Website in whole or in part at any time and to restrict, interrupt or terminate its service. The Website Owner also reserves the right to modify or amend these terms and conditions at any time. If any provision hereunder (or a part thereof) is or becomes illegal, invalid or unenforceable in any respect under any applicable law, the validity, legality and enforceability of the remaining provisions shall not in any way be impaired or affected.
Governing law and jurisdiction
These terms and conditions are exclusively governed by and shall be construed in accordance with the laws of Hong Kong. Each user is subject to the exclusive jurisdiction of the courts of Hong Kong in respect of any disputes arising hereunder.
恒指上日(14日)連續第二日收跌,全日跌312點,收報25502點。大市成交金額1409億。個別股份逆市造好，上日三大升幅藍籌有中石油(0857)、比亞迪(1211)及藥明生物(2269)。
據報，工信部部長在新聞發佈會上表示，新能源汽車是全球汽車領域發展的重要方向，亦是國家汽車發展的戰略選擇。面對當下新能源汽車企業數量太多，處於小而散的狀況，要充分發揮市場作用， 鼓勵企業兼併重組做大做强。電動車龍頭之一的比亞迪(1211)上日一度升4.5%，升穿20天移動平均線，收市前升幅收窄，全日仍能逆市升2.7%，報263元收市。另有大行報告指中國8月份新能源車的佔比高於預期，相信中國新能源車的需求及增長穩固，其中看好的股份包括比亞迪。比亞迪股價近日高位橫行待破，投資者如對其後市走勢看好，或可留意比迪購25593，行使價298.2元，實際槓桿4.9倍，引伸波幅64.6%，換股比率100兌1，2021年12月30日到期。
今早(15日)比亞迪隨大市向下，一度跌逾2.5%，曾見256.4元低位。投資者如認爲其股價短期有機會受大市拖累向下或對後市看淡，或可留意比迪沽16593，行使價220.88元，實際槓桿4.4倍，引伸波幅60.1%，換股比率100兌1，2021年12月30日到期。
平保(2318)跌勢未止，昨日越跌越多，截至收市見全日低位，收報57.6元，跌2.6%，跌穿60元關口，並見52週低位。有大行指，中資保險商新業務疲弱，投資市場波動及剩餘利潤增長放慢，估計下半年盈利下降，更將平保剔出買入名單。平保昨日公佈首八月保費收入5,318億人幣，按年跌5.3%。投資者如對後市看淡，或可留意平保沽25713，行使價52.83元，實際槓桿4.9倍，引伸波幅39.4%，換股比率10兌1，2022年02月25日到期。輪證資金流方面，平保為上日十大好倉流入，淡倉流入的股份之一，但樂觀資金錄得6百萬元，佔整體資金流的63%。今早平保低開1%，隨後跌幅收窄。如認爲短期内有反彈空間，或可留意平保購25811，行使價70.75元，實際槓桿8.6倍，引伸波幅38.2%，換股比率10兌1，2022年01月28日到期。
港股周二見反彈，中資保險股及銀行股板塊繼續領漲大市，重磅藍籌股功不可沒。恆指全日高開高走，於20天移動平均綫企穩後繼續上揚，進而收復10天綫失地，全日反彈226點，收市報26568點，大市交投暢旺，全日成交額超過1500億元。
騰訊（0700）周一急跌之後於50天移動平均綫暫時企穩，周二反彈近3%，再次逼近580元位置，為恆指貢獻70點升幅。有大行預料騰訊第四季及明年游戲收入表現保持强勁，目標價看至700元。周一留意到市場上有不少資金趁騰訊回吐候低部署好倉，令騰訊成爲當日十大好倉流入及淡倉流出的股份之一。北水於周一净流出近3億元之後，周二又重新流入超過9億元。投資者如看好，或可留意騰訊購15696，行使價680.5元，實際槓桿10.7倍，引伸波幅38.1%，換股比率100兌1，2021年02月23日到期。相反，如對騰訊後市看淡或想用認沽證對冲手上持股的話，或可留意騰訊沽15697，行使價525元，實際槓桿2.7倍，引伸波幅36%，換股比率500兌1，2022年04月29日到期。
友邦（1299）、香港電訊及港怡醫院合作,推出保險業界首個由醫院提供服務的遙距醫療服務。令用戶在疫情期間，足不出戶都可安心獲取優質、便利和有效率的專業醫療諮詢服務。友邦周二股價急彈近4%，升穿20天移動平均綫，是恆指成份股中表現最好的股份。投資者如看好，或可留意友邦購18320，行使價96.93元，實際槓桿5.8倍，引伸波幅34.6%，換股比率50兌1，2021年07月27日到期。相反，則可留意友邦沽18031，行使價72.88元，實際槓桿3.5倍，引伸波幅37.1%，換股比率50兌1，2021年12月30日到期。
内險股昨日領漲大市，龍頭股平保（2318）表現令市場驚喜，全日飆升3.6%至94元以上，見6個月以來的高位，吸引北水連續2個交易日净流入追捧。如看好，投資者如看好，或可留意平保購21903，行使價99.99元，實際槓桿5.9倍，引伸波幅25.7%，換股比率50兌1，2021年12月30日到期。看淡，則可留意平保沽18884，行使價83.78元，實際槓桿6.2倍，引伸波幅28.4%，換股比率50兌1，2021年07月29日到期。
恒指季檢結果上週五出爐，染藍個股包括小米（1810），阿里巴巴（9988）以及藥明生物（2269）。當中，阿里巴巴早已是市場大熱之選，而小米及藥明生物則令市場驚喜，另一大熱之選美團（3690）則未被選中，僅被列入恒生國企指數成分股。雖然恒指季檢第一個交易日，染藍股份個別發展，但恒指週一走勢仍能靠穩，全日低開高走，中段升幅一度超過400點，收市前升幅收窄至164點，報25347點收市，大市成交額較上週五有所回升，重返1200億之上。
講到新經濟股，阿里巴巴（9988）昨日的股價不升反跌，或與美國點名提及將對包括阿里巴巴在内的更多中國科技公司施壓。但美國商務部部長羅斯在接受采訪時稱沒有對阿里巴巴採取任何正式行動，其後阿里巴巴於隔晚美股表現亦見回升。阿里巴巴將於本週四（8月20日公佈中期業績，如繼續看好的投資者，或可趁其股價回落的機會候低留意阿里購23527，行使價289元，實際槓桿6.7倍，引伸波幅40.6%，換股比率100兌1，2021年01月26日到期。相反，投資者如看淡，或可留意阿里沽15639，行使價211.08元，實際槓桿6.4倍，引伸波幅40%，換股比率100兌1，2020年12月23日到期。
雖然新經濟股週一表現個別發展，但早前走勢落後的内險股板塊昨日反而見追捧，恒指成分股當中貢獻最多升幅的前三隻股份當中，内險股佔了兩隻，分別有平保（2318）及中人壽（2628）。
平保（2318）預期將於今個月底8月27日公佈中期業績，上週公佈的首7個月原保險合同保費收入按年亦增約0.9%，令市場憧憬内地疫情緩或令平保下一季度保費收入增長，加上平保股價走勢相對落後，如對後市看好，或可留意平保購21565，行使價91元，實際槓桿5.1倍，引伸波幅27.3%，換股比率50兌1，2021年12月30日到期。